STOCK TITAN

CXII (CXII) Stock News

CXII Nasdaq

Welcome to our dedicated page for CXII news (Ticker: CXII), a resource for investors and traders seeking the latest updates and insights on CXII stock.

Churchill Capital Corp XII reports developments centered on shareholder voting matters, capital-structure disclosure, and SPAC-related security structure. Company updates focus on corporate actions that affect voting mechanics, security terms, and issuer organization rather than recurring operating segment results or product-line activity.

Rhea-AI Summary

Churchill Capital Corp XII (Nasdaq: CXIIU) closed an upsized initial public offering of 41,400,000 units at $10.00 per unit, including full exercise of a 5,400,000-unit overallotment, generating $414,000,000 in gross proceeds.

Each unit comprises one Class A ordinary share and one-tenth of a redeemable warrant; whole warrants carry a $11.50 exercise price. Proceeds of $414,000,000 were placed in trust pending a business combination. Units began trading April 28, 2026 on Nasdaq under CXIIU.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Churchill Capital Corp XII (CXII) priced an upsized IPO of 36,000,000 units at $10.00 per unit, raising $360 million before exercise of the underwriter option.

Units (symbol CXIIU) trade on Nasdaq; each unit equals one Class A ordinary share plus one-tenth of a warrant (warrant exercise $11.50). The offering may close April 29, 2026, subject to customary conditions, and includes a 45-day option to sell up to 5,400,000 additional units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags